News
13d
Clinical Trials Arena on MSNCellphire Therapeutics halts enrolment in trial of CLPH-511 after IDMC feedbackThe company expects the final trial visits and the collection of data to take place by the second quarter of this year.
Independent Data Monitoring Committee (the “DMC”) recommends continuation of sunRIZE trial as planned with no need to increase sample size ...
(RTTNews) - Rezolute, Inc. (RZLT) on Wednesday announced that an independent Data Monitoring Committee or DMC has issued a positive recommendation for the ongoing Phase 3 sunRIZE study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results